Therapeutic Area | MeSH |
---|---|
cardiovascular diseases | D002318 |
nutritional and metabolic diseases | D009750 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
hypercholesterolemia | HP_0003124 | D006937 | — |
coronary artery disease | — | D003324 | I25.1 |
hypertriglyceridemia | EFO_0004211 | D015228 | — |
hyperlipoproteinemias | HP_0010980 | D006951 | — |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertriglyceridemia | D015228 | EFO_0004211 | — | — | — | 3 | 1 | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | 2 | — | 1 | 3 |
Myocardial infarction | D009203 | EFO_0000612 | I21 | — | — | 1 | — | 1 | 2 |
Coronary disease | D003327 | — | — | — | — | 1 | — | 1 | 2 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 1 | — | 1 | 2 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | 1 | — | 1 | 2 |
Infarction | D007238 | EFO_0009463 | — | — | — | 1 | — | 1 | 2 |
Drug common name | Clofibrate |
INN | calcium clofibrate |
Description | Clofibrate is the ethyl ester of clofibric acid. It has a role as an anticholesteremic drug, an antilipemic drug, a geroprotector and a PPARalpha agonist. It is an aromatic ether, a member of monochlorobenzenes and an ethyl ester. It is functionally related to a clofibric acid. |
Classification | Small molecule |
Drug class | antihyperlipidemics (clofibrate type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1 |
PDB | — |
CAS-ID | 637-07-0 |
RxCUI | — |
ChEMBL ID | CHEMBL565 |
ChEBI ID | 3750 |
PubChem CID | 2796 |
DrugBank | DB00636 |
UNII ID | TT85QFR500 (ChemIDplus, GSRS) |